Prostate cancer clinical stage does not predict recurrence

A new study challenges the current staging system that determines the extent or severity of prostate cancer that has not metastasised. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study found that there is no link between localised prostate cancer's clinical stage and a patient's risk of cancer recurrence after having his prostate removed...

Read the whole article on

More from